Decision support in surgical management of ischemic cardiomyopathy

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 2, 2010, Pages

  Yoon, Dustin Y ^a   Smedira, Nicholas G ^a   Nowicki, Edward R ^a   Hoercher, Katherine J ^a   Rajeswaran, Jeevanantham ^a   Blackstone, Eugene H ^a   Lytle, Bruce W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MITRAL ANNULOPLASTY; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL;

EID: 74549156513     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.08.055     Document Type: Article

References (36)

1. Allen L.A., and Felker G.M. Advances in the surgical treatment of heart failure. Curr Opin Cardiol 23 (2008) 249-253
2. Boyle C.A., and Decoufle P. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol 131 (1990) 160-168
3. Newman T.B., and Brown A.N. Use of commercial record linkage software and vital statistics to identify patient deaths. J Am Med Inform Assoc 4 (1997) 233-237
4. Blackstone E.H., Naftel D.C., and Turner Jr. M.E. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 81 (1986) 615-624
5. Blackstone E.H. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg 122 (2001) 430-439
6. Breiman L. Bagging predictors. Machine Learning 24 (1996) 123-140
7. Drake C., and Fisher L. Prognostic models and the propensity score. Int J Epidemiol 24 (1995) 183-187
8. Sergeant P., Blackstone E., and Meyns B. Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG.K.U. Leuven Coronary Surgery Program. Eur J Cardiothorac Surg 12 (1997) 1-19
9. Gerds T.A., and Schumacher M. Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biom J 48 (2006) 1029-1040
10. Eagle K.A., Guyton R.A., Davidoff R., Edwards F.H., Ewy G.A., Gardner T.J., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110 (2004) e340-e437
11. Tolis Jr. G.A., Korkolis D.P., Kopf G.S., and Elefteriades J.A. Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation. Ann Thorac Surg 74 (2002) 1476-1481
12. Mihaljevic T., Lam B.K., Rajeswaran J., Takagaki M., Lauer M.S., Gillinov A.M., et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 49 (2007) 2191-2201
13. Wu A.H., Aaronson K.D., Bolling S.F., Pagani F.D., Welch K., and Koelling T.M. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45 (2005) 381-387
14. Gorman R.C., and Gorman J.H. Invited commentary: Tolis GA, Jr. Korkolis DP, Kopf GS, Elefteriades JA. Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation. Ann Thorac Surg 74 (2002) 1481
15. Velazquez E.J., Lee K.L., O'Connor C.M., Oh J.K., Bonow R.O., Pohost G.M., et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 134 (2007) 1540-1547
16. Maxey T.S., Reece T.B., Ellman P.I., Butler P.D., Kern J.A., Tribble C.G., et al. Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg 127 (2004) 428-434
17. Kron I.L., Lerman B.B., Haines D.E., Flanagan T.L., and DiMarco J.P. Coronary artery bypass grafting in patients with ventricular fibrillation. Ann Thorac Surg 48 (1989) 85-89
18. Langenburg S.E., Buchanan S.A., Blackbourne L.H., Scheri R.P., Sinclair K.N., Martinez J., et al. Predicting survival after coronary revascularization for ischemic cardiomyopathy. Ann Thorac Surg 60 (1995) 1193-1197
19. Pasquet A., Lauer M.S., Williams M.J., Secknus M.A., Lytle B., and Marwick T.H. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism. Eur Heart J 21 (2000) 125-136
20. Buckberg G.D. Congestive heart failure: treat the disease, not the symptom-return to normalcy. J Thorac Cardiovasc Surg 121 (2001) 628-637
21. Ratcliffe M.B., and Guy T.S. The effect of preoperative diastolic dysfunction on outcome after surgical ventricular remodeling. J Thorac Cardiovasc Surg 134 (2007) 280-283
22. Burkhoff D., and Wechsler A.S. Surgical ventricular remodeling: a balancing act on systolic and diastolic properties. J Thorac Cardiovasc Surg 132 (2006) 459-463
23. Jones R.H., Velazquez E.J., Michler R.E., Sopko G., Oh J.K., O'Connor C.M., et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 360 (2009) 1705-1717
24. Young J.B. Heart failure's near dead and dying: reconsidering our heart transplant wait list scheme. J Am Coll Cardiol 50 (2007) 1291-1293
25. Lietz K., and Miller L.W. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990-2005. J Am Coll Cardiol 50 (2007) 1282-1290
26. Murphy K.M., and Topel R.H. Measuring the gains from medical research: an economic approach (2003), University of Chicago Press, Chicago
27. Ross P.L., Scardino P.T., and Kattan M.W. A catalog of prostate cancer nomograms. J Urol 165 (2001) 1562-1568
28. Miller G.A. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev 63 (1956) 81-97
29. Kareev Y. Seven (indeed, plus or minus two) and the detection of correlations. Psychol Rev 107 (2000) 397-402
30. Wright P. The harassed decision maker: time pressures, distractions, and the use of evidence. J Appl Psychol 59 (1974) 555-561
31. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
32. Shroyer A.L., Coombs L.P., Peterson E.D., Eiken M.C., DeLong E.R., Chen A., et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 75 (2003) 1856-1865
33. Levy W.C., Mozaffarian D., Linker D.T., Sutradhar S.C., Anker S.D., Cropp A.B., et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113 (2006) 1424-1433
34. Lietz K., Long J., Kfoury A.G., Slaughter M.S., Silver M.A., Milano C.A., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007) 497-505
35. Reason J. Human error: models and management. BMJ 320 (2000) 768-770
36. Blackstone E.H. Thinking beyond the risk factors. Eur J Cardiothorac Surg 29 (2006) 645-652